Involvement of the nucleolus in replication of human viruses

Reviews in Medical Virology

Volumn 19, Issue 4, 2009, Pages 201-214

  Greco, Anna ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CORE PROTEIN; DNA DIRECTED RNA POLYMERASE; FIBRILLARIN; NUCLEAR PROTEIN; NUCLEOLIN; NUCLEOPHOSMIN; PROTEIN CAP; REV PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; UPSTREAM BINDING FACTOR; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; APOPTOSIS; CELL CYCLE REGULATION; COXSACKIE VIRUS B; DNA MODIFICATION; DNA TRANSCRIPTION; DNA VIRUS; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; INFLUENZA VIRUS; NONHUMAN; NUCLEAR IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOLUS; PARAINFLUENZA VIRUS; POLIOMYELITIS VIRUS; PROTEIN LOCALIZATION; REVIEW; RNA TRANSLATION; RNA VIRUS; SARS CORONAVIRUS; TRANSCRIPTION REGULATION; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; WART VIRUS;

EID: 67650921169     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.614     Document Type: Review

References (144)

1. Zimber A, Nguyen QD, Gespach C. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease. Cell Signal 2004; 16: 1085-1104.
2. Olson MO, Dundr M. The moving parts of the nucleolus. Histochem Cell Biol 2005; 123: 203-216.
3. Coute Y, Burgess JA, Diaz JJ, et al. Deciphering the human nucleolar proteome. Mass Spectrom Rev 2006; 25: 215-234.
4. Leung AK, Trinkle-Mulcahy L, Lam YW, et al. NOPdb: nucleolar proteome database. Nucleic Acids Res 2006; 34: D218-220.
5. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI. The multifunctional nucleolus. Nat Rev Mol Cell Biol 2007; 8: 574-585.
6. Hiscox J. RNA viruses: hijacking the dynamic nucleolus. Nat Rev Microbiol 2007; 5: 119-127.
7. Sirri V, Urcuqui-Inchima S, Roussel P, Hernandez-Verdun D. Nucleolus: the fascinating nuclear body. Histochem Cell Biol 2008; 129: 13-31.
8. Ugrinova I, Monier K, Ivaldi C, et al. Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol Biol 2007; 8: 66.
9. Mongelard F, Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol 2007; 17: 80-86.
10. Storck S, Shukla M, Dimitrov S, Bouvet P. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 2007; 41: 125-144.
11. Roussel P, Hernandez-Verdun D. Identification of Ag-NOR proteins, markers of proliferation related to ribosomal gene activity. Exp Cell Res 1994; 214: 465-472.
12. Derenzini M, Sirri V, Trere D, Ochs RL. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995; 73: 497-502.
13. Sirri V, Roussel P, Gendron MC, Hernandez-Verdun D. Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent. Cytometry 1997; 28: 147-156.
14. Okuwaki M. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J Biochem 2008; 143: 441-448.
15. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, Corbett AH. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem 2007; 282: 5101-5105.
16. Carmo-Fonseca M, Mendes-Soares L, Campos I. To be or not to be in the nucleolus. Nat Cell Biol 2000; 2: E107-112.
17. Emmott E, Dove BK, Howell G, et al. Viral nucleolar localisation signals determine dynamic trafficking within the nucleolus. Virology 2008; 380: 191-202.
18. Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003; 163: 871-878.
19. Hovanessian AG, Puvion-Dutilleul F, Nisole S, et al. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 2000; 261: 312-328.
20. Galati D, Paiardini M, Cervasi B, et al. Specific changes in the posttranslational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus. J Infect Dis 2003; 188: 1483-1491.
21. Galati D, Bocchino M. New insights on the perturbations of T cell cycle during HIV infection. Curr Med Chem 2007; 14: 1920-1924.
22. Nisole S, Krust B, Hovanessian A. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp Cell Res 2002; 276: 155-173.
23. Said EA, Courty J, Svab J, Delbe J, Krust B, Hovanessian AG. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J 2005; 272: 4646-4659.
24. Hovanessian AG. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Cell Res 2006; 16: 174-181.
25. Bose S, Basu M, Banerjee AK. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol 2004; 78: 8146-8158.
26. de Verdugo UR, Selinka HC, Huber M, et al. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol 1995; 69: 6751-6757.
27. Fankhauser C, Izaurralde E, Adachi Y, Wingfield P, Laemmli UK. Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element. Mol Cell Biol 1991; 11: 2567-2575.
28. Szebeni A, Mehrotra B, Baumann A, Adam SA, Wingfield PT, Olson MO. Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. Biochemistry 1997; 36: 3941-3949.
29. Li Y-P. Protein B23 is an important human factor of the nucleolar localization of the human immunodeficiency virus protein Tat. J Virol 1997; 71: 4098-4102.
30. Siomi H, Shida H, Maki M, Hatanaka M. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J Virol 1990; 64: 1803-1807.
31. Young TM, Wang Q, Pe'ery T, Mathews MB. The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Mol Cell Biol 2003; 23: 6373-6384.
32. Hoque M, Tian B, Mathews MB, Pe'ery T. Granulin and granulin repeats interact with the Tat.P-TEFb complex and inhibit Tat transactivation. J Biol Chem 2005; 280: 13648-13657.
33. Canto-Nogues C, Hockley D, Grief C, et al. Ultrastructural localization of the RNA of immunodeficiency viruses using electron microscopy in situ hybridization and in vitro infected lymphocytes. Micron 2001; 32: 579-589.
34. Michienzi A, Cagnon L, Bahner I, Rossi JJ. Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA. Proc Natl Acad Sci USA 2000; 97: 8955-8960.
35. Michienzi A, De Angelis FG, Bozzoni I, Rossi JJ. A nucleolar localizing Rev binding element inhibits HIV replication. AIDS Res Ther 2006; 3: 13.
36. Daelemans D, Costes SV, Cho EH, Erwin-Cohen RA, Lockett S, Pavlakis GN. In vivo HIV-1 Rev multimerization in the nucleolus and cytoplasm identified by fluorescence resonance energy transfer. J Biol Chem 2004; 279: 50167-50175.
37. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 2004; 86: 3993-4003.
38. Ristea S, Dobbelstein M, Roth J. Rev protein of human immunodeficiency virus type 1 and cellular exportin 1 protein relocalize each other to a subnucleolar structure. AIDS Res Hum Retroviruses 2000; 16: 857-865.
39. Zolotukhin AS, Felber BK. Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev. J Virol 1999; 73: 120-127.
40. Kramer-Hammerle S, Ceccherini-Silberstein F, Bickel C, et al. Identification of a novel Rev-interacting cellular protein. BMC Cell Biol 2005; 6: 20.
41. Hakata Y, Umemoto T, Matsushita S, Shida H. Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1. J Virol 1998; 72: 6602-6607.
42. Fu L, White KN. Enhancement of nucleocytoplasmic export of HTLV-1 Rex mRNA through cis and trans interactions of the mRNA with the complex of Rex protein and Rex-responsive element. FEBS Lett 1996; 396: 47-52.
43. Nicot C, Dundr M, Johnson JM, et al. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med 2004; 10: 197-201.
44. Adachi Y, Copeland TD, Takahashi C, et al. Phosphorylation of the Rex protein of human T-cell leukemia virus type I. J Biol Chem 1992; 267: 21977-21981.
45. Baydoun H, Duc-Dodon M, Lebrun S, Gazzolo L, Bex F. Regulation of the human T-cell leukemia virus gene expression depends on the localization of regulatory proteins Tax, Rex and p30II in specific nuclear subdomains. Gene 2007; 386: 191-201.
46. Koralnik IJ, Fullen J, Franchini G. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol 1993; 67: 2360-2366.
47. Adachi Y, Copeland TD, Hatanaka M, Oroszlan S. Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B-23. J Biol Chem 1993; 268: 13930-13934.
48. Narayan M, Younis I, D'Agostino DM, Green PL. Functional domain structure of human T-cell leukemia virus type 2 rex. J Virol 2003; 77: 12829-12840.
49. Wistuba A, Kern A, Weger S, Grimm D, Kleinschmidt JA. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J Virol 1997; 71: 1341-1352.
50. Qiu J, Brown KE. A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology 1999; 257: 373-382.
51. Bevington JM, Needham PG, Verrill KC, Collaco RF, Basrur V, Trempe JP. Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions. Virology 2007; 357: 102-113.
52. Johnson JS, Samulski RJ. Enhancement of AAV infection by mobilizing capsids into and out of the nucleolus. J Virol 2009; 83: 2632-2644.
53. Matthews DA. Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm. J Virol 2001; 75: 1031-1038.
54. Bertrand L, Pearson A. The conserved N-terminal domain of herpes simplex virus 1 UL24 protein is sufficient to induce the spatial redistribution of nucleolin. J Gen Virol 2008; 89: 1142-1151.
55. Lee CH, Chang SC, Chen CJ, Chang MF. The nucleolin binding activity of hepatitis delta antigen is associated with nucleolus targeting. J Biol Chem 1998; 273: 7650-7656.
56. Tan KP, Shih KN, Lo SJ. Ser-123 of the large antigen of hepatitis delta virus modulates its cellular localization to the nucleolus, SC-35 speckles or the cytoplasm. J Gen Virol 2004; 85: 1685-1694.
57. Hirano M, Kaneko S, Yamashita T, et al. Direct interaction between nucleolin and hepatitis C virus NS5B. J Biol Chem 2003; 278: 5109-5115.
58. Kusakawa T, Shimakami T, Kaneko S, Yoshioka K, Murakami S. Functional interaction of hepatitis C Virus NS5B with Nucleolin GAR domain. J Biochem 2007; 141: 917-927.
59. Falcon V, Acosta-Rivero N, Chinea G, et al. Nuclear localization of nucleocapsid-like particles and HCV core protein in hepatocytes of a chronically HCV-infected patient. Biochem Biophys Res Commun 2003; 310: 54-58.
60. Otsuka M, Kato N, Lan K, et al. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 2000; 275: 34122-34130.
61. Realdon S, Gerotto M, Dal Pero F, et al. Proapoptotic effect of hepatitis C virus CORE protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation. J Hepatol 2004; 40: 77-85.
62. Brady J, Kashanchi F. Tat gets the "green" light on transcription initiation. Retrovirology 2005; 2: 69.
63. Liu H, Herrmann CH. Differential localization and expression of the Cdk9 42k and 55k isoforms. J Cell Physiol 2005; 203: 251-260.
64. Sweet T, Sawaya BE, Khalili K, Amini S. Interplay between NFBP and NF-kappaB modulates tat activation of the LTR. J Cell Physiol 2005; 204: 375-380.
65. Marcello A, Cinelli RA, Ferrari A, et al. Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer. J Biol Chem 2001; 276: 39220-39225.
66. Michienzi A, Li S, Zaia JA, Rossi JJ. A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc Natl Acad Sci USA 2002; 99: 14047-14052.
67. Li MJ, Kim J, Li S, et al. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol Ther 2005; 12: 900-909.
68. Grinstein E, Wernet P, Snijders PJ, et al. Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J Exp Med 2002; 196: 1067-1078.
69. Grinstein E, Shan Y, Karawajew L, et al. Cell cycle-controlled interaction of nucleolin with the retino-blastoma protein and cancerous cell transformation. J Biol Chem 2006; 281: 22223-22235.
70. Waggoner S, Sarnow P. Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus-infected cells. J Virol 1998; 72: 6699-6709.
71. Izumi RE, Valdez B, Banerjee R, Srivastava M, Dasgupta A. Nucleolin stimulates viral internal ribosome entry site-mediated translation. Virus Res 2001; 76: 17-29.
72. Lu H, Li W, Noble WS, Payan D, Anderson DC. Riboproteomics of the hepatitis C virus internal ribosomal entry site. J Proteome Res 2004; 3: 949-957.
73. Yu Y, Ji H, Doudna JA, Leary JA. Mass spectrometric analysis of the human 40S ribosomal subunit: native and HCV IRES-bound complexes. Protein Sci 2005; 14: 1438-1446.
74. Tollefson AE, Ying B, Doronin K, Sidor PD, Wold WS. Identification of a new human adenovirus protein encoded by a novel late l-strand transcription unit. J Virol 2007; 81: 12918-12926.
75. Rodrigues SH, Silva NP, Delicio LR, Granato C, Andrade LE. The behavior of the coiled body in cells infected with adenovirus in vitro. Mol Biol Rep 1996; 23: 183-189.
76. Okuwaki M, Iwamatsu A, Tsujimoto M, Nagata K. Identification of nucleophosmin/B23, an acidic nucleolar protein, as a stimulatory factor for in vitro replication of adenovirus DNA complexed with viral basic core proteins. J Mol Biol 2001; 311: 41-55.
77. Lawrence FJ, McStay B, Matthews DA. Nucleolar protein upstream binding factor is sequestered into adenovirus DNA replication centres during infection without affecting RNA polymerase I location or ablating rRNA synthesis. J Cell Sci 2006; 119: 2621-2631.
78. Samad MA, Okuwaki M, Haruki H, Nagata K. Physical and functional interaction between a nucleolar protein nucleophosmin/B23 and adenovirus basic core proteins. FEBS Lett 2007; 581: 3283-3288.
79. Hindley CE, Davidson AD, Matthews DA. Relationship between adenovirus DNA replication proteins and nucleolar proteins B23.1 and B23.2. J Gen Virol 2007; 88: 3244-3248.
80. Calle A, Ugrinova I, Epstein AL, Bouvet P, Diaz JJ, Greco A. Nucleolin is required for an efficient herpes simplex virus type 1 infection. J Virol 2008; 82: 4762-4773.
81. Stow ND, Evans VC, Matthews DA. Upstream-binding factor is sequestered into herpes simplex virus type 1 replication compartments. J Gen Virol 2009; 90: 69-73.
82. Shimakami T, Honda M, Kusakawa T, et al. Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon. J Virol 2006; 80: 3332-3340.
83. Huang WH, Yung BY, Syu WJ, Lee YH. The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication. J Biol Chem 2001; 276: 25166-25175.
84. Li YJ, Macnaughton T, Gao L, Lai MM. RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies. J Virol 2006; 80: 6478-6486.
85. Huang WH, Chen YS, Chen PJ. Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication. J Virol 2008; 82: 692-699.
86. Ueno T, Tokunaga K, Sawa H, et al. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1). Microbiol Immunol 2004; 48: 111-118.
87. Jordan P, Mannervik M, Tora L, Carmo-Fonseca M. In vivo evidence that TATA-binding protein/SL1 colocalizes with UBF and RNA polymerase I when rRNA synthesis is either active or inactive. J Cell Biol 1996; 133: 225-234.
88. Tsuji T, Sun Y, Kishimoto K, et al. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 2005; 65: 1352-1360.
89. Sadagopan S, Sharma-Walia N, Veettil MV, et al. Kaposi's Sarcoma Associated Herpes Virus (KSHV/HHV-8) Upregulates Angiogenin During Infection of Human Dermal Microvascular Endothelial Cells Which Induces 45SrRNA Synthesis, Anti-apoptosis, Cell Proliferation, Migration and Angiogenesis. J Virol 2009 [Epub ahead of print].
90. Castiglia CL, Flint SJ. Effects of adenovirus infection on rRNA synthesis and maturation in HeLa cells. Mol Cell Biol 1983; 3: 662-671.
91. Puvion-Dutilleul F, Christensen ME. Alterations of fibrillarin distribution and nucleolar ultrastructure induced by adenovirus infection. Eur J Cell Biol 1993; 61: 168-176.
92. Kao CF, Chen SY, Lee YH. Activation of RNA polymerase I transcription by hepatitis C virus core protein. J Biomed Sci 2004; 11: 72-94.
93. Mai RT, Yeh TS, Kao CF, Sun SK, Huang HH, Wu Lee YH. Hepatitis C virus core protein recruits nucleolar phosphoprotein B23 and coactivator p300 to relieve the repression effect of transcriptional factor YY1 on B23 gene expression. Oncogene 2006; 25: 448-462.
94. Banerjee R, Weidman MK, Navarro S, Comai L, Dasgupta A. Modifications of both selectivity factor and upstream binding factor contribute to polio-virus-mediated inhibition of RNA polymerase I transcription. J Gen Virol 2005; 86: 2315-2322.
95. Cawood R, Harrison SM, Dove BK, Reed ML, Hiscox JA. Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid protein. Cell Cycle 2007; 6: 863-867.
96. You J, Dove BK, Enjuanes L, et al. Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J Gen Virol 2005; 86: 3303-3310.
97. Timani KA, Liao Q, Ye L, et al. Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res 2005; 114: 23-34.
98. You JH, Reed ML, Hiscox JA. Trafficking motifs in the SARS-coronavirus nucleocapsid protein. Biochem Biophys Res Commun 2007; 358: 1015-1020.
99. Surjit M, Liu B, Chow VT, Lal SK. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J Biol Chem 2006; 281: 10669-10681.
100. Zeng Y, Ye L, Zhu S, et al. The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation. Biochem Biophys Res Commun 2008; 369: 287-291.
101. Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 2001; 276: 21529-21537.
102. Khan S, Fielding BC, Tan TH, et al. Over-expression of severe acute respiratory syndrome coronavirus 3b protein induces both apoptosis and necrosis in Vero E6 cells. Virus Res 2006; 122: 20-27.
103. Yuan X, Shan Y, Zhao Z, Chen J, Cong Y. G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. Virol J 2005; 2: 66.
104. Ning B, Shih C. Nucleolar localization of human hepatitis B virus capsid protein. J Virol 2004; 78: 13653-13668.
105. Giraud S, Diaz-Latoud C, Hacot S, Textoris J, Bourette RP, Diaz JJ. US11 of herpes simplex virus type 1 interacts with HIPK2 and antagonizes HIPK2-induced cell growth arrest. J Virol 2004; 78: 2984-2993.
106. Hiscox J. The nucleolus - a gateway to viral infection? Arch Virol 2002; 147: 1077-1089.
107. Emmett SR, Dove B, Mahoney L, Wurm T, Hiscox JA. The cell cycle and virus infection. Methods Mol Biol 2005; 296: 197-218.
108. Dove BK, You JH, Reed ML, Emmett SR, Brooks G, Hiscox JA. Changes in nucleolar morphology and proteins during infection with the coronavirus infectious bronchitis virus. Cell Microbiol 2006; 8: 1147-1157.
109. Reed ML, Howell G, Harrison SM, Spencer KA, Hiscox JA. Characterization of the nuclear export signal in the coronavirus infectious bronchitis virus nucleocapsid protein. J Virol 2007; 81: 4298-4304.
110. Kim SH, Ryabov EV, Brown JW, Taliansky M. Involvement of the nucleolus in plant virus systemic infection. Biochem Soc Trans 2004; 32: 557-560.
111. Kolb G, Reigadas S, Castanotto D, et al. Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication. RNA Biol 2006; 3: 150-156.
112. Michienzi A, Castanotto D, Lee N, Li S, Zaia JA, Rossi JJ. RNA-mediated inhibition of HIV in a gene therapy setting. Ann N Y Acad Sci 2003; 1002: 63-71.
113. Unwalla HJ, Li H, Li SY, Abad D, Rossi JJ. Use of a U16 snoRNA-containing ribozyme library to identify ribozyme targets in HIV-1. Mol Ther 2008; 16: 1113-1119.
114. Elliott G, O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997; 88: 223-233.
115. Helland DE, Welles JL, Caputo A, Haseltine WA. Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol 1991; 65: 4547-4549.
116. Koshizuka T, Takakuwa H, Goshima F, Murata T, Nishiyama Y. The US11 gene product of herpes simplex virus has intercellular trafficking activity. Biochem Biophys Res Commun 2001; 288: 597-602.
117. Lutz P, Puvion-Dutilleul F, Lutz Y, Kedinger C. Nucleoplasmic and nucleolar distribution of the adenovirus IVa2 gene product. J Virol 1996; 70: 3449-3460.
118. Matthews DA, Russell WC. Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli. J Gen Virol 1998; 79: 1671-1675.
119. Lee TW, Blair GE, Matthews DA. Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes. J Gen Virol 2003; 84: 3423-3428.
120. Lee TW, Lawrence FJ, Dauksaite V, Akusjarvi G, Blair GE, Matthews DA. Precursor of human adenovirus core polypeptide Mu targets the nucleolus and modulates the expression of E2 proteins. J Gen Virol 2004; 85: 185-196.
121. Szekely L, Jiang WQ, Pokrovskaja K, Wiman KG, Klein G, Ringertz N. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion. J Gen Virol 1995; 76: 2423-2432.
122. Shire K, Ceccarelli DF, Avolio-Hunter TM, Frappier L. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol 1999; 73: 2587-2595.
123. Kashuba E, Mattsson K, Pokrovskaja K, et al. EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells. Int J Cancer 2003; 105: 644-653.
124. Kashuba E, Yurchenko M, Szirak K, Stahl J, Klein G, Szekely L. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein. Exp Cell Res 2005; 303: 47-55.
125. Arcangeletti MC, De Conto F, Ferraglia F, et al. Human cytomegalovirus proteins PP65 and IEP72 are targeted to distinct compartments in nuclei and nuclear matrices of infected human embryo fibroblasts. J Cell Biochem 2003; 90: 1056-1067.
126. Chou S, Marousek GI, Senters AE, Davis MG, Biron KK. Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir. J Virol 2004; 78: 7124-7130.
127. Salsman J, Zimmerman N, Chen T, Domagala M, Frappier L. Genome-wide screen of three herpes-viruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog 2008; 4: e1000100.
128. Lopez-Iglesias C, Puvion-Dutilleul F, Cebrian J, Christensen ME. Herpes simplex virus type 1-induced modifications in the distribution of nucleolar B-36 protein. Eur J Cell Biol 1988; 46: 259-269.
129. Leopardi R, Roizman B. Functional interaction and colocalization of the herpes simplex virus 1 major regulatory protein ICP4 with EAP, a nucleolar-ribosomal protein. Proc Natl Acad Sci USA 1996; 93: 4572-4576.
130. Roller RJ, Monk LL, Stuart D, Roizman B. Structure and function in the herpes simplex virus 1 RNA-binding protein U(s)11: mapping of the domain required for ribosomal and nucleolar association and RNA binding in vitro. J Virol 1996; 70: 2842-2851.
131. Mears WE, Rice SA. The herpes simplex virus immediate-early protein ICP27 shuttles between nucleus and cytoplasm. Virology 1998; 242: 128-137.
132. Catez F, Erard M, Schaerer-Uthurralt N, Kindbeiter K, Madjar J-J, Diaz J-J. Unique motif for nucleolar retention and nuclear export regulated by phosphorylation. Mol Cell Biol 2002; 22: 1126-1139.
133. Cheng G, Brett ME, He B. Signals that dictate nuclear, nucleolar, and cytoplasmic shuttling of the gamma(1)34.5 protein of herpes simplex virus type 1. J Virol 2002; 76: 9434-9445.
134. Morency E, Coute Y, Thomas J, Texier P, Lomonte P. The protein ICP0 of herpes simplex virus type 1 is targeted to nucleoli of infected cells. Brief report. Arch Virol 2005; 150: 2387-2395.
135. Lymberopoulos MH, Pearson A. Involvement of UL24 in herpes-simplex-virus-1-induced dispersal of nucleolin. Virology 2007; 363: 397-409.
136. Lopez MR, Schlegel EF, Wintersteller S, Blaho JA. The major tegument structural protein VP22 targets areas of dispersed nucleolin and marginalized chromatin during productive herpes simplex virus 1 infection. Virus Res 2008; 136: 175-188.
137. Hong-Yan Z, Murata T, Goshima F, et al. Identification and characterization of the UL24 gene product of herpes simplex virus type 2. Virus Genes 2001; 22: 321-327.
138. Yamada H, Jiang YM, Zhu HY, Inagaki-Ohara K, Nishiyama Y. Nucleolar localization of the UL3 protein of herpes simplex virus type 2. J Gen Virol 1999; 80: 2157-2164.
139. Zhu HY, Yamada H, Jiang YM, Yamada M, Nishiyama Y. Intracellular localization of the UL31 protein of herpes simplex virus type 2. Arch Virol 1999; 144: 1923-1935.
140. Daelemans D, Afonina E, Nilsson J, et al. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export. Proc Natl Acad Sci USA 2002; 99: 14440-14445.
141. Hivin P, Basbous J, Raymond F, et al. The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Retrovirology 2007; 4: 14.
142. Melen K, Kinnunen L, Fagerlund R, et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 2007; 81: 5995-6006.
143. Murayama R, Harada Y, Shibata T, et al. Influenza A virus non-structural protein 1 (NS1) interacts with cellular multifunctional protein nucleolin during infection. Biochem Biophys Res Commun 2007; 362: 880-885.
144. Yuan X, Li J, Shan Y, et al. Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Res 2005; 109: 191-202.